Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Phospho-Nucleophosmin (Ser125) Antibody (6B830) is a Rabbit antibody targeting Phospho-Nucleophosmin (Ser125). Anti-Phospho-Nucleophosmin (Ser125) Antibody (6B830) can be used in ICC/IF, IHC, IHC-Fr, WB.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $369 | 7-10 days | 7-10 days | |
| 100 μL | $677 | 7-10 days | 7-10 days |
| Description | Anti-Phospho-Nucleophosmin (Ser125) Antibody (6B830) is a Rabbit antibody targeting Phospho-Nucleophosmin (Ser125). Anti-Phospho-Nucleophosmin (Ser125) Antibody (6B830) can be used in ICC/IF, IHC, IHC-Fr, WB. |
| Synonyms | p-Nucleophosmin (Ser125), p-Nucleophosmin (S125), Numatrin, nucleophosmin nucleoplasmin family member 1, Nucleophosmin (p-Ser125), Nucleophosmin (p-S125), Nucleophosmin, NPM1, NPM, NO38 |
| Ig Type | IgG |
| Clone | 6B830 |
| Reactivity | Human,Mouse,Rat |
| Specificity | Phospho-Nucleophosmin (Ser125) |
| Application | |
| Recommended Dose | ICC/IF: 1:50-1:200; IHC: 1:100-1:200; IHC-Fr: 1:50-1:200; WB: 1:1000-1:2000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Purification | Affinity-chromatography |
| Appearance | Liquid |
| Formulation | Supplied in 10 mM phosphate buffered saline, pH 7.4, 150 mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Research Background | Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. |
| Conjucates | Unconjugated |
| Immunogen | A synthesized peptide: human Nucleophosmin around the phosphorylation site of S125 |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.